Inside the stem-cell pharmaceutical factory
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Nature 582, S16-S18 (2020)
This article is part of Nature Outlook: Extracellular RNA, an editorially independent supplement produced with the financial support of third parties. About this content.
Chen, T. S. Nucleic Acids Res. 38, 215–224 (2010).
Ibrahim, A. G.-E., Cheng, K. & Marbán, E. Stem Cell Rep. 2, 606–619 (2014).
Kordelas, L. et al. Leukemia 28, 970–973 (2014).
Kodali, M. et al. Int. J. Mol. Sci. 21, 181 (2020).
Williams, A. M. J. Neurotrauma 36, 54–60 (2019).
Xin, H. J. Cerebr. Blood. F. Met. 33, 1711–1715 (2013).
Rogers, R. et al. JCI Insight 4, e125754 (2019).
De Couto, G. Circulation 136, 200–214 (2017).
Kamerkar, S. et al. Nature 546, 498–503 (2017).
Toh, W. S., Lai, R. C., Zhang, B., & Lim, S. K. Biochem. Soc. Trans. 46, 843–853 (2018).